logo

Restorbio, Inc. (TORC)



Trade TORC now with
  Date
  Headline
3/25/2019 10:29:28 AM Wedbush Is Raising resTORbio, Inc. (TORC) FY19 Estimate To -1.66 From -2.73
3/25/2019 10:29:13 AM Wedbush Is Increasing resTORbio, Inc. (TORC) Q4 19 Estimate To -0.56 From -0.82
3/25/2019 10:29:00 AM Wedbush Is Increasing resTORbio, Inc. (TORC) Q3 19 Estimate To -0.45 From -0.69
3/25/2019 10:24:27 AM Wedbush Is Raising resTORbio, Inc. (TORC) Q2 19 Estimate To -0.38 From -0.70
3/25/2019 10:24:09 AM Wedbush Is Raising resTORbio, Inc. (TORC) Q1 19 Estimate To -0.27 From -0.52
3/19/2019 8:59:48 PM ResTORbio Prices Underwritten Public Offering Of 7.20 Mln Shares At $6.95/shr
2/6/2019 8:34:30 AM ResTORbio Appoints Erkan Baloglu As VP, Drug Discovery And Medicinal Chemistry
10/16/2018 7:13:31 AM ResTORbio Announces Additional Positive Results From Dose-ranging Phase 2b Clinical Trial Of RTB101
8/15/2018 8:04:04 AM ResTORbio Appoints Jeffrey Chodakewitz To Its Board
8/9/2018 8:19:31 AM ResTORbio Q2 Net Loss $13.6 Miln Or $0.48/Shr Vs Loss Of $4.1 Mln Or $0.94/Shr Last Year
5/11/2018 7:49:26 AM Wedbush Is Raising resTORbio, Inc. (TORC) FY19 Estimate To -2.18 From -2.24
5/11/2018 7:49:13 AM Wedbush Is Raising resTORbio, Inc. (TORC) Q4 19 Estimate To -0.51 From -0.60
5/11/2018 7:48:58 AM Wedbush Is Cutting resTORbio, Inc. (TORC) Q3 19 Estimate To -0.60 From -0.59
5/11/2018 7:48:46 AM Wedbush Is Lowering resTORbio, Inc. (TORC) Q2 19 Estimate To -0.56 From -0.55
5/11/2018 7:48:29 AM Wedbush Is Lowering resTORbio, Inc. (TORC) Q1 19 Estimate To -0.51 From -0.50
5/11/2018 7:48:13 AM Wedbush Is Lowering resTORbio, Inc. (TORC) FY18 Estimate To -1.67 From -1.45
5/11/2018 7:47:54 AM Wedbush Is Cutting resTORbio, Inc. (TORC) Q3 18 Estimate To -0.40 From -0.39
5/11/2018 7:47:40 AM Wedbush Is Lowering resTORbio, Inc. (TORC) Q2 18 Estimate To -0.38 From -0.34
5/9/2018 8:33:19 AM ResTORbio Completes Dosing In Phase 2b Trial Evaluating Safety, Tolerability And Efficacy Of RTB101
  
 
>